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CD21-Positive Follicular Dendritic Cells
A Possible Source of PrPSc in Lymph Node Macrophages of
Scrapie-Infected Sheep
Lynn M. Herrmann,* William P. Cheevers,†
William C. Davis,† Donald P. Knowles,*† and
Katherine I. O’Rourke*
Animal Disease Research Unit,* Agricultural Research Service,
U.S. Department of Agriculture, Pullman; and the Department of
Veterinary Microbiology and Pathology,† Washington State
University, Pullman, Washington
Natural sheep scrapie is a prion disease characterized
by the accumulation of PrPSc in brain and lymphoid
tissues. Previous studies suggested that lymph node
macrophages and follicular dendritic cells (FDC) ac-
cumulate PrPSc. In this study, lymph nodes were an-
alyzed for the presence of PrPSc and macrophage or
FDC markers using dual immunohistochemistry. A
monoclonal antibody (mAb) to the C-terminus of PrP
reacted with CD172a macrophages and CD21 FDC
processes in secondary follicles. However, a PrP N-
terminus-specific mAb reacted with CD21 FDC pro-
cesses but not CD172a macrophages in secondary
follicles. Neither the PrP N-terminus nor C-terminus-
specific mAb reacted with CD172a macrophages in
the medulla. These results indicate that lymph node
follicular macrophages acquire PrPSc by phagocytosis
of CD21 FDC processes. The results also suggest that
follicular macrophages have proteases that process
full-length PrPSc to N-terminally truncated PrPSc.
(Am J Pathol 2003, 162:1075–1081)
Natural sheep scrapie is part of a group of fatal neuro-
degenerative diseases termed transmissible spongiform
encephalopathies (TSEs) or prion diseases. Sheep
scrapie is characterized by the accumulation of a pro-
tease-resistant protein designated PrPSc. Since PrPSc
and the infectious component co-purify, the presence of
PrPSc is considered a marker for TSEs.1 One predomi-
nant theory suggests that PrPSc is formed by post-trans-
lational modification of a normal host-derived protease-
sensitive prion protein, PrPc.2,3
PrPSc is detected in the brains of scrapie-infected
sheep using immunohistochemistry (IHC) with PrP mono-
clonal antibodies (mAb).4–7 In most scrapie-infected
sheep, PrPSc also accumulates in the lymphoid tissues. In
addition, lymph node tissue from scrapie-infected sheep
injected intracerebrally into mice induces clinical
scrapie.8 Spleen, lymph nodes, gastrointestinal-associ-
ated lymphoid tissue (GALT), tonsils, and lymphoid tissue
of the nictitating membrane or “third eyelid” from scrapie-
infected sheep contain PrPSc in secondary lymphoid fol-
licles.9–12
Some experiments have indicated that there are two
PrPSc-positive cell types in lymphoid tissues of scrapie-
infected sheep: tingible body macrophages based on
morphology using light microscopy and follicular den-
dritic cells (FDC) based on morphology and CD21 co-
localization with PrPSc using serial sections.13,14 The
present study evaluated PrPSc-positive cell types in
lymph node of scrapie-infected sheep by dual IHC using
mAb to PrP and macrophage or FDC markers. In addi-
tion, mAb to the C-terminus and N-terminus of PrP were
used to examine macrophages and FDC for the presence
of full-length and truncated PrPSc.
Materials and Methods
Animals
Normal Suffolk sheep were defined by absence of PrPSc
in the lymphoid tissue of the third eyelid, lymph nodes,
and brain using IHC.15 Scrapie-infected Suffolk sheep
were defined as sheep with natural field scrapie experi-
encing clinical signs and containing PrPSc in the lym-
phoid tissue of the third eyelid and brain using IHC.15
Four normal and scrapie-infected sheep were used in this
study. All sheep were homozygous for glutamine at PrP
position 171.
Western Blot Analysis
Brain lysates were prepared with and without proteinase
K (PK) at 50 g/ml using a direct tissue homogenate
protocol as described.16 Western blots were performed
as described16 and probed with PrP mAb 99/97.6.1 or
5B2.16
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Tissue Sections
Frozen sections of prescapular and retropharyngeal
lymph nodes to be used for IHC (see below) were cut at
6 m on positively charged glass slides (Superfrost,
Fisher Scientific), fixed in 10% buffered formalin for 10
minutes, and air dried.
Dissociation of Retropharyngeal and
Prescapular Lymph Nodes
Retropharyngeal and prescapular lymph nodes not used
for tissue sections were cut in small pieces and placed
into sterile Hank’s buffered salt solution for mechanical
disruption. Lymph node tissue was disrupted in a 1.5-ml
sterile microcentrifuge tube using a 1-ml syringe plunger.
Dissociated lymph node (DLN) cells were passed
through a 70-m Falcon filter and centrifuged at 1500 
g for 10 minutes at 4°C. Filtered DLN cells were sus-
pended in phosphate-buffered saline (PBS), 10 mmol/L
ethylene diaminetetraacetic acid (EDTA) and centrifuged
at 500  g for 10 minutes at 4°C following lysis of red
blood cells (RBCs) with three volumes of RBC lysis solu-
tion (Gentra). DLN cells were suspended in PBS (pH 7.2),
10% acid citrate dextrose, 0.1% NaN3, 2% -globulin-
free horse serum, 1% phenol red, centrifuged at 500  g
for 5 minutes at 4°C, and counted in 0.4% trypan blue.
Aliquots of washed DLN cells were used for flow cytom-
etry or IHC. DLN cells used for IHC were suspended in
10% neutral-buffered formalin for at least 10 minutes,
placed on positively charged slides, and air-dried over-
night.
Flow Cytometry
DLN cells were analyzed for specific cell surface mark-
ers following previous indirect staining protocols.17
DLN cells were stained with the primary mAbs shown in
Table 1. DLN cells were subsequently stained with the
following fluorescein isothiocyanate (FITC) or phyco-
erythrin (PE)-conjugated secondary antibodies: FITC-
conjugated goat anti-mouse IgM (Caltag) (1:100),
FITC-conjugated goat anti-mouse IgG2a (Caltag) (1:
100), FITC-conjugated goat anti-mouse IgG2b (Caltag)
(1:100), and PE-conjugated goat-anti-mouse IgG1
(Caltag) (1:100). Negative controls included isotype
mAbs substituted for mAbs listed in Table 1 and sec-
ondary antibodies used alone without primary antibod-
ies. Cells were resuspended in 200 l 1X PBS/2%
formaldehyde and analyzed on a FACSort flow cytom-
eter. A total of 10,000 events were analyzed.
Immunohistochemistry (IHC)
Formalin-fixed tissue sections or DLN cells on positively
charged glass were placed into 1X Tris-buffered saline
tween (TBST) (Dako) for 5 minutes. Slides were placed
into citrate target retrieval buffer pH 6.0 (Dako) and incu-
bated in a pressurized decloaker for 20 minutes at 121°C
and 20 psi (decloaking). The slides were cooled 30 min-
utes and transferred into 1X TBST (Dako) for 5 to 10
minutes. IHC was performed at room temperature. The
first IHC used the LSAB2 Kit (Dako), and the second IHC
used the second part of the Envision Doublestain kit
(Dako) following the manufacturer’s instructions. After
dual IHC, slides were counterstained with Mayer’s hemo-
toxylin (Lillie’s Modified, Dako) for 1 minute, washed in
Milli Q water, dipped repeatedly in 37 mmol/L ammonium
hydroxide, and washed in Milli Q water. Slides were
mounted in aqueous mounting solution (Dako) and ex-
Figure 1. Western blot analysis of brain and lymph node from scrapie-
infected sheep using mAbs 99/97.6.1 and 5B2. Lanes 1–3 were detected with
3 g/ml of mAb 99/97.6.1 and lanes 4–6 were detected with 2 g/ml of
mAb 5B2. Lanes 1 and 2 contain 200 g of brain tissue, and lanes 4 and 5
contain 800 g of brain tissue. Lanes 3 and 6 contain 2.4 mg of retropha-
ryngeal lymph node tissue. Molecular weights are given on the left.
Table 1. Flow Cytometric Analysis of Dissociated Lymph Node Cells
mAb Marker
Mean percentage of positive
cells  standard deviation Reference(s)
BAQ15A CD21 12.63  10.25 36
BAQ44A B2 46.98  13.03 37
BAQ153A CD11c 5.7  1.24 38
H58A MHC Class I 87.58  11.86 20
H42A MHC Class II 49.46  10.86 20
MUC76A CD11a/18 68.4  17.37 39
GC1A, 7C2B, GB54A CD4, CD8, WC1 59.65  9.99 19
Pig45A2 SIgM 22.14  13.10 20
8H4 PrP 55.12  16.65 23
DH59B MYD1 15.11  1.49 18–21
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amined by light microscopy. Digital photomicrography
used a Zeiss Axioshop 2 plus microscope equipped with
AxioCam imaging software. The following monoclonal an-
tibodies (mAb) were used in the first IHC: DH59B
(IgG1),
18–21 GB25A (IgG1),
19,22 and TH21A (IgG2a).
20
Either PrP C-terminus-specific mAb 99/97.6.1 (epitope at
220–225aa)15 or PrP N-terminus-specific mAb 5B2
(epitope at 34–52aa)23 were used in the second IHC.
Irrelevant isotype control antibodies coli S 69A (IgG1) and
coli S 205A (IgG2a) (WSU monoclonal antibody lab) were
singly substituted for 99/97.6.1, DH59B, GB25A, and
TH21A in dual IHC and served as negative controls.
Negative reagent controls consisted of using the first
mAb in the first IHC sequence followed by all of the dual
IHC steps of the second IHC sequence.
Results
Western Blot Analysis of PK-Resistant PrP from
Brain and Lymph Nodes of Scrapie-Infected
Sheep Using mAbs 99/97.6.1 and 5B2
Both mAb 99/97.6.1 and 5B2 bind to full-length PrP from
sheep brain; however, mAb 5B2 does not bind to N-
terminally truncated forms of PrP from sheep brain.15,23
We confirmed the reactivities of these mAbs by Western
blot of brain and lymph node homogenates treated with
and without PK. Figure 1 (lanes 1 and 4) shows that both
mAb 99/97.6.1 and 5B2 recognized PrP from brain of a
scrapie-infected sheep. Following digestion with PK,
mAb 99/97.6.1 recognized PK-resistant PrP in brain and
lymph node (Figure 1, lanes 2 and 3), whereas mAb 5B2
did not react with PK-resistant PrP in brain and lymph
node (Figure 1, lanes 5 and 6). Since the N-terminus of
PrPSc is removed by PK,1 these results confirm mAb 5B2
recognizes only full-length PrP, whereas mAb 99/97.6.1 rec-
ognizes both full-length and N-terminally truncated PrP.
Distribution of PrPSc in Secondary Follicles of
Prescapular Lymph Node Using PrP mAbs
PrPSc was detected in secondary follicles of prescapular
and retropharyngeal lymph nodes of sheep with clinical
scrapie using PrP C-terminus-specific mAb 99/97.6.1 or
PrP N-terminus-specific mAb 5B2. As reported previous-
ly,24 PrPSc was not detected in lymph nodes of normal
sheep using either mAb 99/97.6.1 or mAb 5B2 (not
shown). In secondary lymphoid follicles, mAb 99/97.6.1
detected PrPSc in many macrophage-like cells (defined
by nuclear morphology) and to a lesser extent associated
with intercellular structures resembling FDC processes.
(Figure 2A). However, PrPSc detected by mAb 5B2 was
observed predominantly in FDC processes (Figure 2B).
An IgG1 isotype control mAb did not stain secondary
follicles (Figure 2C).
PrPSc and CD172a Co-Localize in Secondary
Follicle Macrophages of Prescapular Lymph
Nodes Using PrP mAb 99/97.6.1
To confirm the presence of PrPSc in macrophages of
lymph node secondary follicles, dual IHC using a mac-
Figure 2. IHC detection of PrPSc in secondary follicles of prescapular lymph
node sections using two different PrP mAbs. A: PrP mAb 99/97.6.1 at 10
g/ml (Fast Red). Oil magnification, 63. B: PrP mAb 5B2 at 10 g/ml (Fast
Red). Oil magnification,63. C: Isotype control mAb at 15 g/ml substituted
for PrP mAb 99/97.6.1 (Fast Red). Oil magnification, 63.
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rophage-granulocyte cell-specific mAb (DH59B) and PrP
mAb 99/97.6.1 was performed. The mAb DH59B binds to
signal regulatory protein  MYD-1 or CD172a on macro-
phages and granulocytes.18 Macrophages expressing
CD172a were abundant in both secondary follicles and
medulla of prescapular lymph nodes (Figure 3A). Using
mAb 99/97.6.1 (Fast Red), PrPSc co-localized with
CD172a (DAB) in follicular macrophages (Figure 3B).
However, CD172a follicular macrophages did not con-
tain PrPSc recognized by N-terminus-specific mAb 5B2
(Figure 3C). Medullary macrophages expressing
CD172a did not contain detectable PrPSc using either
mAb 99/97.6.1 or mAb 5B2 (not shown).
PrPSc and CD21 Co-Localize in Secondary
Follicles of Prescapular Lymph Nodes Using
Either PrP mAb 99/97.6.1 or PrP mAb 5B2
FDC are considered a major cell type that accumulates
PrPSc in secondary lymphoid follicles of scrapie-infected
mice and sheep.13–14,25–29 Since PrPSc was found in FDC
processes (Figure 2A and 2B), dual IHC was performed
with CD21 mAb GB25A and PrP mAb 99/97.6.1 or PrP
mAb 5B2. Figure 4A shows the distribution of CD21 in
secondary follicles of prescapular lymph nodes of
scrapie-infected sheep. As expected, FDC processes
were positive for CD21 (Figure 4A, arrow 1). CD21 mAb
GB25A also stained cells resembling tingible body mac-
rophages (Figure 4A, arrow 2). Tingible body macro-
phages are defined as macrophages containing bodies
in their cytoplasm. As expected from the distribution of
PrP staining in Figure 2A, PrP mAb 99/97.6.1 (Fast Red)
co-localized with intercellular CD21 FDC processes
(DAB) (Figure 4B, arrow 1) as well as CD21 macro-
phage-like cells (Figure 4B, arrow 2; Figure 4C). Similar to
PrP C-terminus mAb 99/97.6.1, N-terminus PrP mAb 5B2
co-localized with CD21 FDC processes (Figure 4D).
However, mAb 5B2 did not stain CD21 tingible body
macrophages, supporting the data in Figure 3C indicat-
ing that this PrP N-terminus mAb did not stain CD 172a
macrophages.
IHC Analysis of DLN Cells
The unexpected finding that follicular macrophage-like
cells were double-positive for PrPSc using mAb 99/97.6.1
and CD21 was pursued further using DLN cells to better
define membrane boundaries and cell morphology. Flow
cytometry of DLN cells from four sheep was used to verify
the presence of major lymphoid cell types. Table 1 shows
the mAbs used in flow cytometry, the cell surface target
of the mAb, and the mean and standard deviation (SD) of
the percentage of positive cells for each mAb. These
data demonstrate that the major lymphoid cell types were
represented in DLN cells.
In DLN cells from scrapie-infected sheep, IHC with PrP
mAb 99/97.6.1 detected PrPSc in macrophage-like cells
and membrane debris (not shown). Confirming the lymph
node section results in Figure 3B, greater than 95% of
Figure 3. Dual IHC co-localization of PrPSc and CD172a in secondary follicle
macrophages of prescapular lymph node sections of scrapie-infected sheep
using a PrP C-terminal mAb 99/97.6.1. A: CD172a mAb DH59B at 15 g/ml
(DAB) with isotype control mAb (15 g/ml) substituted for PrP mAb 99/
97.6.1 (Fast Red). Magnification of medulla and secondary follicles, 40. B:
CD172a mAb DH59B at 15 g/ml (DAB) with PrP mAb 99/97.6.1 at 10 g/ml
(Fast Red). Oil magnification of secondary follicles, 63. C: CD172a mAb
DH59B at 15 g/ml (DAB) with PrP mAb 5B2 at 10 g/ml (Fast Red).
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PrPSc-positive macrophage-like cells in DLN cells co-
localized with the macrophage marker CD172a. Most of
these macrophages were tingible body macrophages
(Figure 5A). Consistent with the results in Figures 4B and
4C, PrPSc also co-localized with intracellular CD21 in
many PrPSc tingible body macrophages (Figure 5B).
PrPSc macrophages also co-localized with major histo-
compatibility complex (MHC) class II in 30% of PrPSc-
positive macrophages (Figure 5C).
Discussion
In the present study, PrPSc and CD21 co-localized in
intercellular FDC processes in secondary follicles of
lymph node sections from sheep with clinical scrapie
using PrP N-terminus-specific mAb 5B2 or PrP C-termi-
nus-specific mAb 99/97.6.1. Following dissociation of
lymph nodes, these PrPSc CD21 processes were
recovered as membrane fragments (not shown). Pre-
vious studies by others also indicate that FDC contain
PrPSc.13–14,25–29 We also detected both CD 21 and PrPSc
(using mAb 99/97.6.1) in follicular macrophages of lymph
node sections as well as macrophages in DLN prepara-
tions. These cells were identified definitively by expres-
sion of a macrophage marker (CD172a). We attribute the
presence of CD21 in follicular macrophages to phagocy-
tosis of FDC, since others have shown that germinal
center macrophages acquire antigen-containing FDC
processes or iccosomes by phagocytosis.30–31 Others
have also shown that CD68 follicular macrophages
contain PrPSc using either a PrP polyclonal Ab R521
(raised to a peptide 94–105aa) or PrP mAb 2G11
(epitope at 151–159aa).32
Interestingly, we did not detect PrPSc using the PrP
N-terminus mAb 5B2 (epitope 34–52) in follicular macro-
phages of lymph node sections. One possibility for this
observation is that the N-terminus of PrPSc is removed by
macrophage proteases. Thus, PrPSc in lymphoid follicular
Figure 4. Dual IHC co-localization of PrPSc and CD21 in FDC processes of secondary follicles of prescapular lymph node sections of scrapie-infected sheep
using either a PrP C-terminal-specific mAb 99/97.6.1 or a PrP N-terminal-specific mAb 5B2. A: CD21 mAb GB25A at 15 g/ml (DAB) with isotype control
mAb (15 g/ml) substituted for PrP mAb 99/97.6.1 (Fast Red). Oil magnification, 63. Arrow 1 denotes CD21 FDC processes and arrow 2 denotes
CD21 cell resembling a tingible body macrophage. B: CD21 mAb GB25A at 1.5 g/ml (DAB) with PrP mAb 99/97.6.1 at 10 g/ml (Fast Red). Oil
magnification, 63. Arrow 1 denotes PrPSc co-localization with intercellular CD21. Arrow 2 denotes PrPSc co-localization with intracellular CD21 in a
macrophage-like cell. C: Digital close-up of arrow 2 region in Figure 4B. D: CD21 mAb GB25A at 1.5 g/ml (DAB) with PrP mAb 5B2 at 10 g/ml (Fast
Red). Oil magnification, 63.
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macrophages may be equivalent to an N-terminally trun-
cated form of PrPSc commonly found in brain.1
An important question in the pathogenesis of scrapie is
the source of N-terminally truncated PrPSc in follicular
macrophages. The present study indicates that macro-
phages in secondary lymph node follicles of sheep with
clinical scrapie acquire PrPSc by phagocytosis of FDC
processes and remove the N-terminus of PrPSc. Macro-
phages in the lymph node medulla are another possible
source of PrPSc in follicular macrophages, since second-
ary follicle macrophages are derived from medullary
macrophages.33 However, CD172a macrophages in
the lymph node medulla did not contain PrPSc using PrP
mAb 99/97.6.1 or PrP mAb 5B2. Importantly, medullary
macrophages were also negative for the FDC CD21
marker. Therefore, the finding that PrPSc and CD21
co-localization in macrophages was confined to lymph
node secondary follicles demonstrates that follicular
macrophages acquired PrPSc and CD21 exogenously.
Since follicular B lymphocytes express CD21,34 tingible
body macrophages may acquire CD21 by phagocytosis
of B lymphocytes. However, since B lymphocytes are
negative for PrPSc,32,35 FDC processes are the most likely
source of PrPSc and CD21 in follicular macrophages.
In addition to acquisition of PrPSc by phagocytosis,
macrophages may produce N-terminally truncated PrPSc
constitutively. However, the absence of PrPSc in lymph
node medullary macrophages using the PrP mAb 99/
97.6.1 suggests that macrophages do not produce
PrPSc. In addition, PrPSc is not detected in peripheral
blood monocytes of sheep with clinical scrapie using PrP
mAb 99/97.6.1.35
In summary, this study presents IHC results identifying
PrPSc FDC processes as the probable source of PrPSc
in macrophages of secondary lymph node follicles and
that these macrophages remove the N-terminus of PrPSc.
This raises the possibility that FDC may be the only cells
in lymphoid tissue which produce full-length PrPSc. In
mice, ME7 strain scrapie pathogenesis is dependent on
FDC and not bone marrow-derived cells expressing
PrPc.25 Therefore, FDC expressing PrPc may be the crit-
ical lymphoid cells in sheep scrapie pathogenesis as
well. If this is the case, PrPSc may bind to surface ex-
posed PrPc on FDC processes, resulting in PrPc to PrPSc
conversion, and follicular macrophages then acquire
PrPSc by phagocytosis and proteolytically remove the
N-terminus from PrPSc. An important question for future
studies is whether follicular lymphoid macrophages par-
ticipate in the spread of N-terminally truncated PrPSc to
brain.
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